Summary

Gilead Sciences, Inc. is a leading American biopharmaceutical company headquartered in Foster City, California, that specializes in researching, developing, and commercializing innovative medicines for life-threatening diseases. Founded in 1987, Gilead has grown into a global healthcare leader with approximately 17,600 employees worldwide. The company's primary therapeutic focus areas include HIV/AIDS, viral hepatitis (hepatitis B and C), oncology, inflammation, and respiratory diseases. Gilead is renowned for its groundbreaking antiviral therapies, including Sovaldi and Harvoni for hepatitis C, and its comprehensive portfolio of HIV treatments such as Truvada, Atripla, and Biktarvy. The company also developed Veklury (remdesivir) for COVID-19 treatment. Gilead operates as a publicly traded company on the NASDAQ (GILD) and is a component of both the Nasdaq-100 and S&P 100 indices. Through strategic acquisitions like Kite Pharma and Immunomedics, Gilead has expanded into cell therapy and oncology, demonstrating its commitment to advancing medical science and improving patient outcomes globally.

Job description

Key Responsibilities

Execute manufacturing processes on the floor under supervision, following batch records, SOPs, and cGMP regulations to ensure safe and compliant operations.
Ensure right-the-first-time performance of all process steps specific to the phase or stage of operation and help drive the safety-first culture at Kite Oceanside.
Work as part of a team to execute GMP runs in close collaboration with MSAT, Facilities and Engineering (F&E), and Quality departments.
Under supervision, perform weighing of raw materials and electronic inventory transactions utilizing MES and EBS.
Under supervision, perform chromatography and UFDF purification unit operations for the manufacturing of viral vector products in a cGMP environment using proper aseptic technique, cleanroom behavior, GDP, and sound scientific methods.
Prepare and use single use systems to support buffer preparation and filter integrity testing.
Assist with manual and/or automated fill of harvested viral vector material.
Escalate processing and equipment issues as needed.
Assist with revisions of SOPs, Manufacturing Production Records (MPRs), and other controlled documents.
Assist in the review of in-process cGMP documentation for completeness, accuracy, and compliance.
Ability to work effectively in an inclusive, cross-functional, team-based environment.
Able to work off shift hours and weekends and overtime.
Additional duties as assigned.

Basic Qualifications

High School diploma with at least 3 years of relevant experience.
Associates degree with at least 2 years of relevant experience.
Bachelors degree with relevant experience.
Prior experience in a cGMP-regulated industry is required.

Requirements

High School diploma with at least 3 years of relevant experience
Associates degree with at least 2 years of relevant experience
Bachelors degree with relevant experience
Prior experience in a cGMP-regulated industry is required
Ability to work off shift hours, weekends, and overtime

Benefits

Medical, Dental & Vision
Life Insurance
Paid Time Off
Discretionary Annual Bonus
Discretionary Stock-Based Long-Term Incentives

Company overview

Gilead Sciences, Inc. is a leading American biopharmaceutical company headquartered in Foster City, California, that specializes in researching, developing, and commercializing innovative medicines for life-threatening diseases. Founded in 1987, Gilead has grown into a global healthcare leader with approximately 17,600 employees worldwide. The company's primary therapeutic focus areas include HIV/AIDS, viral hepatitis (hepatitis B and C), oncology, inflammation, and respiratory diseases. Gilead is renowned for its groundbreaking antiviral therapies, including Sovaldi and Harvoni for hepatitis C, and its comprehensive portfolio of HIV treatments such as Truvada, Atripla, and Biktarvy. The company also developed Veklury (remdesivir) for COVID-19 treatment. Gilead operates as a publicly traded company on the NASDAQ (GILD) and is a component of both the Nasdaq-100 and S&P 100 indices. Through strategic acquisitions like Kite Pharma and Immunomedics, Gilead has expanded into cell therapy and oncology, demonstrating its commitment to advancing medical science and improving patient outcomes globally.